Evidence map

ReviewTherapeutic advances in endocrinology and metabolism2014

Renal effects of dapagliflozin in patients with type 2 diabetes.

Merlin C ThomasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25126408